iRhythm Technologies, Inc. (IRTC) News

iRhythm Technologies, Inc. (IRTC): $127.67

-5.31 (-3.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter IRTC News Items

IRTC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IRTC News Highlights

  • For IRTC, its 30 day story count is now at 14.
  • Over the past 23 days, the trend for IRTC's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
  • ACAD, CPT and STAR are the most mentioned tickers in articles about IRTC.

Latest IRTC News From Around the Web

Below are the latest news stories about iRhythm Technologies Inc that investors may wish to consider to help them evaluate IRTC as an investment opportunity.

iRhythm extends gains as Oppenheimer upgrades on Novitas’ update

After adding more than a quarter to its value on Monday, iRhythm Technologies (IRTC +6.9%) continues to trade higher as the market weighs in on the updated reimbursement rates published by Novitas for External Electrocardiographic Recording Codes for 2022. Arguing that the rates published by the Medicare Administrative Contractor (MAC)...

Seeking Alpha | January 11, 2022

iRhythm Technologies (IRTC) Investor Presentation - Slideshow

The following slide deck was published by iRhythm Technologies, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 11, 2022

Strength Seen in iRhythm Technologies (IRTC): Can Its 27.6% Jump Turn into More Strength?

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Yahoo | January 11, 2022

Needham Maintains a Hold Rating on Irhythm Technologies (IRTC)

Needham analyst David Saxon maintained a Hold rating on Irhythm Technologies (IRTC – Research Report) today. The company's shares closed last Monday at $128.80. According to TipRanks.com, Saxon is a 2-star analyst with an average return of 1.2% and a 26.3% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, NuVasive, and SI-Bone. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Irhythm Technologies with a $124.00 average price target, implying a 21.0% upside from current levels. In a report issued on January 7, Morgan Stanley also maintained a Hold rating on the stock with a $129.00 price target.

Catie Powers on TipRanks | January 10, 2022

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Irhythm Technologies (IRTC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on ACADIA Pharmaceuticals (ACAD – Research Report) and Irhythm Technologies (IRTC – Research Report). ACADIA Pharmaceuticals (ACAD) In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on ACADIA Pharmaceuticals, with a price target of $42.00. The company's shares closed last Monday at $21.93, close to its 52-week low of $15.68. According to TipRanks.

Brian Anderson on TipRanks | January 10, 2022

IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today

Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement!

William White on InvestorPlace | January 10, 2022

Market Update: Why Are Stocks Down Today?

It's time for a Monday market update as we answer the question "why are stocks down today?", and list companies taking a dive.

William White on InvestorPlace | January 10, 2022

iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on ​​the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC), regarding updated rates applicable to the Current Procedural Terminology (CPT) codes 93243 and 93247. On January 10, 2022, Novitas updated reimbursement rates for CPT codes 93243 and 93247 for the Houston juri

Yahoo | January 10, 2022

While shareholders of iRhythm Technologies (NASDAQ:IRTC) are in the black over 5 years, those who bought a week ago aren't so fortunate

iRhythm Technologies, Inc. ( NASDAQ:IRTC ) shareholders might be concerned after seeing the share price drop 13% in the...

Yahoo | January 10, 2022

Morgan Stanley Maintains a Hold Rating on Irhythm Technologies (IRTC)

Morgan Stanley analyst Cecilia Furlong maintained a Hold rating on Irhythm Technologies (IRTC – Research Report) today and set a price target of $129.00. The company's shares closed last Friday at $102.90. According to TipRanks.com, Furlong is a 5-star analyst with an average return of 33.2% and a 63.0% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Edwards Lifesciences. Currently, the analyst consensus on Irhythm Technologies is a Moderate Buy with an average price target of $124.00.

Catie Powers on TipRanks | January 7, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6424 seconds.